Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DUALITY

Financiado

Cerrado

An Integrated Computational and Experimental Approach to Rapid Synthesis of High...

An Integrated Computational and Experimental Approach to Rapid Synthesis of Highly Selective Dual Targeted HDAC CK2 MMP2 CK2 Inhibitors Traditional drug design strategy based on a single target has serious difficulties in developing new therapies for diseases such as cancer. Cancer is a very complex multi-genetic disease that involves multiple crosstalks between s... ver más

09/04/2020

CEU

170K€

Presupuesto del proyecto: 170K€

Líder del proyecto

FUNDACION UNIVERSITARIA SAN PABLO CEU No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 20

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-04-09

MSCA-IF-2016: Individual Fellowships

I+D

Cerrada hace 8 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

CEU

170.12K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

CTQ2014-52604-R MODULADORES MULTIDIANA COMO ESTRATEGIA PARA EL DISEÑO DE NUE... 80K€ Cerrado

RTI2018-093539-B-I00 PROTACS, TUMOR-TARGETED INHIBITORS AND PROBES FOR CANCER DET... 85K€ Cerrado

COMPUT DRUG DESIGN Targeting the mutated PI3K isoform for the development of n... 100K€ Cerrado

PI3K MODULATORS Identification and characterisation of new class of PI3K mod... 213K€ Cerrado

SMART Small Molecule Antagonists of chromatin modifying enzymes fo... 230K€ Cerrado

CDK6-DrugOpp CDK6 in transcription turning a foe in a friend 2M€ Cerrado

Duración del proyecto: 36 meses Fecha Inicio: 2017-03-21
Fecha Fin: 2020-04-09

Líder del proyecto

FUNDACION UNIVERSITARIA SAN PABLO CEU No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 20

Presupuesto del proyecto 170K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Traditional drug design strategy based on a single target has serious difficulties in developing new therapies for diseases such as cancer. Cancer is a very complex multi-genetic disease that involves multiple crosstalks between signaling networks. The use of cocktails of various anticancer agents interfering with different mechanisms has been the standard treatment to prevent the problems of resistance. An alternative approach is to design multi-target modulators, directed to different disease mechanisms. That is the approach we have chosen for this project, where we seek to design, synthesize and evaluate new dual agents based on the inhibition of three enzymes involved in the development and progression of tumor processes: HDAC1, CK2 and MMP2. CK2 is a serine / threonine kinase that is constitutively active and essential for cell viability. Its proliferative and anti-apoptotic properties create a favorable cellular environment for tumor progression and maintenance and, therefore, constitutes an interesting target for the treatment of cancer. Acetylation/deacetylation of histones is one of the epigenetic mechanisms that regulates gene expression. HDACs (histone deacetylases) remove acetyl groups from histones, inducing condensation of chromatin and, therefore, the repression of gene transcription. For this reason, they are considered key targets to reverse aberrant epigenetic changes associated with cancer. Matrix metalloproteinases (MMPs), also called matrixins are another family of Zn-dependent enzymes. Our research group has extensive experience in the design and synthesis of inhibitors of MMP2 provided with high activity and, more importantly, high selectivity over other metalloproteinases. The design of multi-target modulators will be carried out making use of computational techniques and based on the previous experience of the group in the design and synthesis of inhibitors of these three targets through a fragment based process.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores